Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-09-24Clinical Trial Update: Chemotherapy With or Without Surgery in Treating Patients With Recurrent Ovarian Cancer [Phase 3]
A Phase 3 trial evaluating chemotherapy with or without surgery for recurrent ovarian cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2012-09-21Clinical Trial Update: Combination Chemotherapy in Treating Patients With Metastatic Ovarian Cancer or Non-small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial update on a combination chemotherapy regimen for metastatic ovarian cancer and non-small cell lung cancer, and the …
-
CLINICAL_TRIALS trial_result · 2012-09-18Clinical Trial Update: Conformal Radiation Therapy in Treating Patients With Metastatic Cancer Outside the Brain [Phase 2]
A Phase 2 clinical trial evaluating conformal radiation therapy for metastatic cancers outside the brain was terminated, with results posted…
-
CLINICAL_TRIALS trial_result · 2012-09-12Clinical Trial Update: Phase II Study of Clinical Activity of Pegaspargase in Women With Relapsed or Refractory Epithelial Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer [Phase 2]
Phase II trial evaluating the activity of pegaspargase in women with relapsed or refractory epithelial ovarian cancer, fallopian tube cancer…
-
CLINICAL_TRIALS trial_result · 2012-09-06Clinical Trial Update: Safety Study of a Liposomal Docetaxel Formulation in Patients With Solid Tumors Who Have Failed Previous Therapies [Phase 1]
Phase 1 safety study of a liposomal docetaxel formulation in patients with solid tumors who have failed prior therapy has been completed, ev…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-08-27Clinical Trial Update: Quality-of-Life Assessment in Patients With Ovarian Cancer
This clinical trial update summarizes quality-of-life outcomes for patients with ovarian cancer in a completed study sponsored by EORTC.
-
CLINICAL_TRIALS trial_result · 2012-08-24Clinical Trial Update: S0009 Combination Chemo and Surgery in Stage III or Stage IV Ovarian Cancer [Phase 2]
Phase 2 SWOG trial evaluating the combination of chemotherapy and surgery for stage III or IV ovarian cancer; results were posted after comp…
-
CLINICAL_TRIALS trial_result · 2012-08-23Clinical Trial Update: TEACO: Taxotere, Eloxatin, Avastin in Cancer of the Ovary [Phase 2]
Phase 2 trial TEACO tested a combination of Taxotere (docetaxel), Eloxatin (oxaliplatin), and Avastin (bevacizumab) in ovarian cancer. The s…
-
CLINICAL_TRIALS trial_result · 2012-08-23Clinical Trial Update: A Phase 2, Single-Arm Study of Volociximab Monotherapy in Subjects With Platinum-Resistant Advanced Epithelial Ovarian Cancer or Primary Peritoneal Cancer [Phase 2]
Phase 2, single-arm study of volociximab monotherapy in platinum-resistant advanced epithelial ovarian cancer and primary peritoneal cancer …
-
CLINICAL_TRIALS withdrawal · 2012-08-21Clinical Trial Update: Olaparib for Patients With Recurrent BRCA Deficient Ovarian Cancer [Phase 2]
The Phase 2 trial of olaparib for recurrent BRCA-deficient ovarian cancer has been withdrawn (also related peritoneal and fallopian tube can…
-
CLINICAL_TRIALS trial_result · 2012-08-14Clinical Trial Update: Docetaxel and Carboplatin as First-line Chemotherapy in Early Stage as Well as Advanced or Metastatic Ovarian Cancer
The trial evaluated first-line chemotherapy with docetaxel and carboplatin in ovarian cancer (including early-stage and advanced/metastatic …
-
CLINICAL_TRIALS trial_result · 2012-08-13Clinical Trial Update: Docetaxel in Treating Women With Ovarian Epithelial or Primary Peritoneal Cancer [Phase 2]
A Phase 2 trial evaluating docetaxel in women with ovarian epithelial cancer or primary peritoneal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2012-08-09Clinical Trial Update: Counseling Interventions for BRCA 1/2 Cancer Susceptibility Testing [NA]
This clinical trial update documents that a study evaluating counseling interventions for BRCA1/2 cancer susceptibility testing has complete…
-
CLINICAL_TRIALS trial_result · 2012-08-02Clinical Trial Update: PS-341 Plus Carboplatin in Platinum and Taxane Resistant Recurrent Ovarian Cancer, Primary Peritoneal Cancer, and Fallopian Tube Cancer [Phase 1]
Phase 1 trial evaluating PS-341 (bortezomib) in combination with carboplatin for platinum- and taxane-resistant recurrent ovarian cancer, pr…
-
CLINICAL_TRIALS trial_result · 2012-08-02Clinical Trial Update: PEG-Interferon Alfa-2b in Treating Patients With Platinum-Resistant Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer [Phase 1, Phase 2]
A terminated Phase 1/2 trial evaluating PEG-interferon alfa-2b in platinum-resistant ovarian, fallopian tube, and peritoneal cancer.
-
CLINICAL_TRIALS research · 2012-08-01Clinical Trial Update: Ovarian Cancer Patient Questionnaire on Genetic Testing
A completed clinical trial update from MD Anderson on a study involving genetic testing in ovarian cancer patients, focusing on a patient qu…
-
CLINICAL_TRIALS research · 2012-07-31Clinical Trial Update: ICON8: Weekly Chemotherapy in Ovarian Cancer [Phase 3]
This entry reports on the ICON8 Phase 3 clinical trial evaluating weekly chemotherapy in ovarian cancer, with the current status listed as u…
-
CLINICAL_TRIALS research · 2012-07-30Clinical Trial Update: Identifying Genetic Markers That Predict Response to Paclitaxel in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer
A terminated clinical trial update investigates whether genetic markers can predict response to paclitaxel in patients with newly diagnosed …
-
CLINICAL_TRIALS research · 2012-07-18Clinical Trial Update: Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With Malignancies [Phase 1]
Phase 1 trial evaluating intravenous palifosfamide-tris in combination with etoposide and carboplatin in patients with various malignancies;…
-
CLINICAL_TRIALS trial_result · 2012-07-13Clinical Trial Update: Search Allelic Imbalance of Expression of BRCA Genes in Hereditary Risk of Breast and/or Ovarian Cancer [Phase 2]
Phase 2 clinical trial update investigating allelic imbalance of BRCA gene expression in individuals at hereditary risk for breast and/or ov…
-
CLINICAL_TRIALS trial_result · 2012-07-11Clinical Trial Update: Safety and Efficacy Study of Catumaxomab to Treat Ovarian Cancer After a Complete Response to Chemotherapy [Phase 2]
Phase 2 safety and efficacy study of catumaxomab for ovarian cancer after a complete response to chemotherapy has completed, with results po…
-
CLINICAL_TRIALS trial_result · 2012-07-02Clinical Trial Update: Docetaxel in Treating Patients With Recurrent or Refractory Germ Cell Cancer [Phase 2]
A Phase 2 clinical trial evaluates docetaxel for recurrent or refractory germ cell cancers, including extragonadal germ cell tumors, ovarian…
-
CLINICAL_TRIALS trial_result · 2012-06-29Clinical Trial Update: Comparison of Paclitaxel/Carboplatin and Lonafarnib to Paclitaxel/Carboplatin for First-line Treatment of Ovarian Cancer [Phase 2]
A Phase 2 trial evaluating adding lonafarnib to standard Paclitaxel/Carboplatin for first-line treatment of epithelial ovarian cancer has be…
-
CLINICAL_TRIALS trial_result · 2012-06-26Clinical Trial Update: Vandetanib to Treat Women With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
This Phase 2 trial evaluated vandetanib for ovarian, fallopian tube, and primary peritoneal cancers; the study was terminated and results we…
-
CLINICAL_TRIALS trial_result · 2012-06-12Clinical Trial Update: Determine MTD, Evaluate Efficacy and Safety of Genexol®-PM Plus Carboplatin With Advanced Ovarian Cancer [Phase 1]
Phase 1 trial evaluating the maximum tolerated dose and safety, with early efficacy signals, of Genexol®-PM plus carboplatin in advanced ova…